|
1
|
Endo A, Fuchigami T, Hasegawa M, et al:
Posterior reversible encephalopathy syndrome in childhood: report
of four cases and review of the literature. Pediatr Emerg Care.
28:153–157. 2012.PubMed/NCBI
|
|
2
|
Casey SO, Sampaio RC, Michel E, et al:
Posterior reversible encephalopathy syndrome: utility of
fluid-attenuated inversion recovery MR imaging in the detection of
cortical and subcortieal lesions. AJNR Am J Neuroradiol.
21:1199–1260. 2000.PubMed/NCBI
|
|
3
|
Hinchey J, Chaves C, Appignani B, et al: A
reversible posterior leukoencephalopathy syndrome. N Engl J Med.
334:494–500. 1996. View Article : Google Scholar
|
|
4
|
Ikeda M, Ito S, Hataya H, Honda M and Anbo
K: Reversible posterior leukoencephalopathy in a patient with
minimal-change nephrotic syndrome. Am J Kidney Dis. 37:E302001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Utsumi K, Amemiya S, Lizuka M, Lino Y and
Katayama Y: Acute posterior leukoencephalopathy in a patient with
nephrotic syndrome. Clin Exp Nephrol. 7:63–66. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gümüş H, Per H, Kumandaş S and Yikilmaz A:
Reversible posterior leukoencephalopathy syndrome in childhood:
report of nine cases and review of the literature. Neurol Sci.
31:125–131. 2010.PubMed/NCBI
|
|
7
|
Zhang YX, Liu JR, Ding MP, et al:
Reversible posterior encephalopathy syndrome in systemic lupus
erythematosus and lupus nephritis. Intern Med. 47:867–875. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Das CJ and Seith A: Posterior reversible
encephalopathy syndrome (PRES). Indian Pediatr. 43:657–658.
2006.PubMed/NCBI
|
|
9
|
Lee VH, Wijdicks EF, Manno EM, et al:
Clinical spectrum of reversible posterior leukoencephalopathy
syndrome. Arch Neurol. 65:205–210. 2008.PubMed/NCBI
|
|
10
|
Bartynski WS and Boardman JF: Distinct
imaging patterns and lesion distribution in posterior reversible
encephalopathy syndrome. AJNR Am J Neuroradiol. 28:1320–1327. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rajasekhar A and George TJ Jr:
Gemcitabine-induced reversible posterior leukoencephalopathy
syndrome: a case report and review of the literature. Oncologist.
12:1332–1335. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stott VL, Hurrell MA and Anderson TJ:
Reversible posterior leukoencephalopathy syndrome: a misnomer
reviewed. Intern Med J. 35:83–90. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamamoto A, Hayakawa K and Houjyou M: CT
and MRI findings of cyclosporine-related encephalopathy and
hypertensive encephalopathy. Pediatr Radiol. 32:340–343. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reinohs M, Straube T, Baum P, Berrouschot
J and Wagner A: Recurrent reversible cerebral edema after long term
immunosuppression with tacrolimus. J Neurol. 249:780–781. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bhatt A, Farooq MU, Majid A and Kassab M:
Chemotherapy-related posterior reversible leukoencephalopathy
syndrome. Nat Clin Pract Neurol. 5:163–169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ishikura K, Ikeda M, Hamasaki Y, et al:
Nephrotic state as a risk factor for developing posterior
reversible encephalopathy syndrome in paediatric patients with
nephrotic syndrome. Nephrol. Dial Transplant 23:2531–2536.
2008.
|
|
17
|
Fugate JE, Claassen DO, Cloft HJ, Kallmes
DF, Kozak OS and Rabinstein AA: Posterior reversible encephalopathy
syndrome: associated clinical and radiologic findings. Mayo Clin
Proc. 85:427–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pavlakis SG, Frank Y, Kalina P, et al:
Occipital-parietal encephalopathy: a new name for an old syndrome.
Pediatr Neurol. 16:145–148. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garg RK: Posterior leukoencephalopathy
syndrome. Postgrad Med J. 77:24–28. 2001. View Article : Google Scholar
|
|
20
|
Schwartz RB: Hyperperfusion
encephalopathies: hypertensive encephalopathy and related
conditions. Neurologist. 8:22–34. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kwon S, Koo J and Lee S: Clinical spectrum
of reversible posterior leukoencephalopathy syndrome. Pediatr
Neurol. 24:361–364. 2001. View Article : Google Scholar
|
|
22
|
Singh N, Bonham A and Fukui M:
Immunosuppressive-associated leukoencephalopathy in organ
transplant recipients. Transplantation. 69:467–472. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gijtenbeek JM, van den Bent MJ and Vecht
CJ: Cyclosporine neurotoxicity: a review. J Neurol. 246:339–346.
1999. View Article : Google Scholar
|
|
24
|
Truwit CL, Denaro CP, Lake JR and DeMareo
T: MR imaging of reversible cyclosporine A-induced neurotoxicity.
AJNR Am J Neuroradiol. 12:651–659. 1991.PubMed/NCBI
|
|
25
|
Vlasveld LT, Cornelissen JJ, Dellemijn PL,
Joosse MV and van den Bent MJ: Cortical blindness during treatment
with cyclosporine. Ned Tijdschr Geneeskd. 138:2057–2061. 1994.(In
Dutch).
|
|
26
|
Garg RK: Posterior leukoencephalopathy
syndrome. Postgrad Med J. 77:24–28. 2001. View Article : Google Scholar
|
|
27
|
Schwartz RB, Bravo SM, Klufas RA, et al:
Cyclosporine neurotoxicity and its relationship to hypertensive
encephalopathy: CT and MR findings in 16 cases. AJR AM J
Roentgennol. 165:627–631. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hamano T, Takeda T, Morita H, et al:
Posterior reversible encephalopathy syndrome following measles
vaccination. J Neurol Sci. 298:124–126. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rebora AE and Regesta G: Reversible
posterior leukoencephalopathy: a possible threat for psoriatic
patients treated with biological agents. J Eur Acad Dermatol
Venereol. 24:97–98. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mavragni CP, Vhchoyiannopoulos PC, Kosmas
N, et al: A case of reversible posterior leucoencephalopathy
syndrome after rituximab infusion. Rheumatology (Oxford).
43:1450–1451. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kumar S and Rajam L: Posterior reversible
encephalopathy syndrome (PRES/RPLS) during pulse steroid therapy in
macrophage activation syndrome. Indian J Pediatr. 78:1002–1004.
2011. View Article : Google Scholar
|
